Leerink Partners Maintains Outperform on Compugen, Lowers Price Target to $5

Benzinga Newsdesk www.benzinga.com Negative 93.1%

Neg 93.1% Neu 0% Pos 0%

Leerink Partners maintains Compugen (NASDAQ:CGEN) with a Outperform and lowers the price target from $13 to $5.

Comments

No comments yet. Be the first!